Considering the role of the NLRP3 inflammasome in inducing metabolic disorders, the inhibitory effect of licochalcone A on the NLRP3 inflammasome may mediate the blockade of high-fat diet-induced obesity and metabolic disorders by the compound. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.